Gritstone bio was a clinical-stage American biotechnology company which attempted to develop cancer and infectious disease immunotherapies and vaccines. It was founded in August 2015 as Gritstone Oncology, Inc., with offices in Emeryville, California.
In September 2021 it raised $55.0 million from the sale of 5,000,000 shares. From Wikipedia
